Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Xiao-Qing Jia
Accumulation of P53 Is Prognostic for Aromatase Inhibitor Resistance in Early-Stage Postmenopausal Patients With ER-positive Breast Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Related publications
Moesin Is an Independent Prognostic Marker for ER‑positive Breast Cancer
Oncology Letters
Cancer Research
Oncology
Efficacy of Adjuvant Aromatase Inhibitor in Hormone Receptor-Positive Postmenopausal Breast Cancer Patients According to the Body Mass Index
British Journal of Cancer
Cancer Research
Oncology
Prospective Characterization of Musculoskeletal Symptoms in Early Stage Breast Cancer Patients Treated With Aromatase Inhibitors
Breast Cancer Research and Treatment
Cancer Research
Oncology
Letrozole (CGS 20267), a New Oral Aromatase Inhibitor for the Treatment of Advanced Breast Cancer in Postmenopausal Patients
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Immunofluorometrically Determined P53 Accumulation as a Prognostic Indicator in Italian Breast Cancer Patients
International Journal of Cancer
Cancer Research
Oncology
Managing Arthralgia in a Postmenopausal Woman Taking an Aromatase Inhibitor for Hormone-Sensitive Early Breast Cancer: A Case Study
Cancer Management and Research
Oncology
Guidelines for Osteoprotection in Breast Cancer Patients on an Aromatase Inhibitor
Breast Care
Surgery
Oncology
Anastrozole as Aromatase Inhibitor – New Approaches to Breast Cancer Treatment in Postmenopausal Women
Nowotwory
Cancer Research
Oncology
Correction: Close and Stable Relationship Between Proliferation and a Hypoxia Metagene in Aromatase Inhibitor-Treated ER-Positive Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology